The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
04/17/2012
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
W81XWH-12-LCRP-IDA
Opportunity Category:
Discretionary
Posted Date:
Apr 17, 2012
Creation Date:
Apr 17, 2012
Original Closing Date for Applications:
Sep 20, 2012
Current Closing Date for Applications:
Sep 20, 2012
Archive Date:
Oct 20, 2012
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
4
Estimated Total Program Funding:
$2,240,000
Award Ceiling:
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The Lung Cancer Research Program Idea Development Award is designed to promote new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This mechanism supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths from lung cancer. Applications should include well-formulated, testable hypothesis based on strong scientific rationale.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
PA HELP and eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Help Desk
Synopsis Modification History
There are currently no modifications for this opportunity.
